ARTERIOSCLEROSIS
Clinical trials for ARTERIOSCLEROSIS explained in plain language.
Never miss a new study
Get alerted when new ARTERIOSCLEROSIS trials appear
Sign up with your email to follow new studies for ARTERIOSCLEROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill could slash heart risks for millions
Disease control OngoingThis Phase 3 trial is testing an oral drug called MK-0616 (enlicitide decanoate) in about 14,550 people at high risk for heart problems. The drug aims to lower cholesterol and reduce the chance of major events like heart attacks, strokes, and emergency artery procedures. Particip…
Matched conditions: ARTERIOSCLEROSIS
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New stent shows promise in unclogging heart arteries
Disease control OngoingThis study tests a newer drug-coated stent (Resolute Onyx) against an older one (Resolute Integrity) in 550 people with blocked heart arteries in China. The goal is to see if the new stent works better at keeping arteries open after angioplasty. Participants receive one of the tw…
Matched conditions: ARTERIOSCLEROSIS
Phase: NA • Sponsor: Medtronic Vascular • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New stent aims to keep heart arteries open longer
Disease control OngoingThis study tests a special stent coated with a drug called zotarolimus to treat people with blocked heart arteries. The stent is placed during a procedure to open the artery and slowly releases medication to prevent re-blockage. About 591 participants in China are being followed …
Matched conditions: ARTERIOSCLEROSIS
Phase: NA • Sponsor: Medtronic Vascular • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Heart check revolution: new models may spare thousands from unneeded scans
Diagnosis ENROLLING_BY_INVITATIONThis study tests whether personalized risk models can safely reduce the number of diagnostic tests for people with new chest pain. Researchers will enroll 2,000 adults aged 30-75 and compare the model-based approach to standard care. They will also test a new laser method to meas…
Matched conditions: ARTERIOSCLEROSIS
Phase: PHASE3 • Sponsor: Gødstrup Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 08:05 UTC